US Patent Issued to AIC246 on Sept. 22 for "Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-y1-3-[2-methoxy-5-(trifluoromethyl)phenyl-4H-quinazolin-4-ylacetate monohydrate, its preparation and use" (German, Spanish Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,943, issued on Sept. 22, was assigned to AIC246 AG & Co. KG (Wuppertal, Germany).

"Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-y1-3-[2-methoxy-5-(trifluoromethyl)phenyl-4H-quinazolin-4-ylacetate monohydrate, its preparation and use" was invented by Helmut Buschmann (Aachen, Germany), Thomas Goldner (Velbert, Germany) and Jordi Carles Ceron Bertran (La Pobla de Montornes, Spain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The compound 3,4-dihydroquinazoline sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate monohydrate of formula (I) is particularly useful ...